Strategic Blueprint LLC Increases Holdings in Oracle Corporation (NYSE:ORCL)

Strategic Blueprint LLC raised its holdings in Oracle Corporation (NYSE:ORCL - Free Report) by 125.9% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The firm owned 12,737 shares of the enterprise software provider's stock after buying an additional 7,098 shares during the quarter. Strategic Blueprint LLC's holdings in Oracle were worth $1,781,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently modified their holdings of the business. Norges Bank bought a new stake in Oracle during the fourth quarter worth $2,216,314,000. GAMMA Investing LLC increased its position in shares of Oracle by 15,012.3% during the 1st quarter. GAMMA Investing LLC now owns 4,755,096 shares of the enterprise software provider's stock valued at $664,810,000 after purchasing an additional 4,723,631 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in shares of Oracle by 20.5% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 13,825,360 shares of the enterprise software provider's stock worth $2,303,858,000 after purchasing an additional 2,350,448 shares during the period. Vanguard Group Inc. raised its stake in shares of Oracle by 1.5% during the 4th quarter. Vanguard Group Inc. now owns 157,411,949 shares of the enterprise software provider's stock worth $26,231,127,000 after purchasing an additional 2,296,069 shares during the period. Finally, Kovitz Investment Group Partners LLC boosted its holdings in shares of Oracle by 268.4% in the 4th quarter. Kovitz Investment Group Partners LLC now owns 3,077,947 shares of the enterprise software provider's stock worth $512,909,000 after buying an additional 2,242,520 shares during the last quarter. 42.44% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other Oracle news, insider Clayton M. Magouyrk sold 15,000 shares of the business's stock in a transaction that occurred on Tuesday, June 17th. The stock was sold at an average price of $214.10, for a total value of $3,211,500.00. Following the completion of the sale, the insider owned 60,722 shares in the company, valued at approximately $13,000,580.20. The trade was a 19.81% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Naomi O. Seligman sold 2,866 shares of the firm's stock in a transaction that occurred on Monday, May 5th. The stock was sold at an average price of $149.53, for a total transaction of $428,552.98. Following the completion of the transaction, the director owned 31,764 shares in the company, valued at $4,749,670.92. This represents a 8.28% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 440,366 shares of company stock valued at $83,103,603 over the last three months. 42.20% of the stock is owned by corporate insiders.

Oracle Price Performance

ORCL traded up $7.41 during trading on Friday, reaching $237.39. The stock had a trading volume of 18,441,376 shares, compared to its average volume of 10,140,491. The company has a debt-to-equity ratio of 4.07, a quick ratio of 0.75 and a current ratio of 0.75. The business has a 50-day moving average of $178.14 and a 200-day moving average of $164.26. Oracle Corporation has a one year low of $118.86 and a one year high of $237.99. The stock has a market cap of $666.79 billion, a PE ratio of 54.70, a PEG ratio of 3.55 and a beta of 1.39.

Oracle (NYSE:ORCL - Get Free Report) last announced its quarterly earnings data on Wednesday, June 11th. The enterprise software provider reported $1.70 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.64 by $0.06. Oracle had a net margin of 21.68% and a return on equity of 87.34%. The company had revenue of $15.90 billion during the quarter, compared to analysts' expectations of $15.58 billion. During the same quarter in the prior year, the company earned $1.63 EPS. The firm's revenue was up 11.3% on a year-over-year basis. As a group, equities research analysts anticipate that Oracle Corporation will post 5 EPS for the current fiscal year.

Oracle Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, July 24th. Shareholders of record on Thursday, July 10th will be given a dividend of $0.50 per share. The ex-dividend date is Thursday, July 10th. This represents a $2.00 annualized dividend and a yield of 0.84%. Oracle's payout ratio is 46.08%.

Wall Street Analysts Forecast Growth

Several brokerages have commented on ORCL. Loop Capital set a $135.00 price objective on shares of Oracle in a research report on Tuesday, June 10th. Barclays reiterated an "overweight" rating and issued a $221.00 price objective (up previously from $202.00) on shares of Oracle in a research note on Friday, June 13th. BMO Capital Markets raised their target price on Oracle from $235.00 to $245.00 and gave the stock an "outperform" rating in a research report on Wednesday. Morgan Stanley restated an "overweight" rating on shares of Oracle in a research note on Wednesday, June 18th. Finally, Evercore ISI reiterated a "buy" rating on shares of Oracle in a research note on Wednesday, June 18th. Ten research analysts have rated the stock with a hold rating, twenty-two have assigned a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat, Oracle has an average rating of "Moderate Buy" and a consensus target price of $204.15.

About Oracle

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.